Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCR2 antagonist 5 (JNJ-41443532) 是一种具有选择性和口服活性的 hCCR2 抑制剂,具有良好的结合亲和力 (IC50=37 nM) 和有效的功能拮抗作用 (chemotaxis IC50=30 nM)。JNJ-41443532 对 mCCR2 结合的 Ki 为 9.6 µM, 可用于研究炎症性疾病和糖尿病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 760 | 现货 | ||
5 mg | ¥ 1,860 | 现货 | ||
10 mg | ¥ 2,770 | 现货 | ||
25 mg | ¥ 4,590 | 现货 | ||
50 mg | ¥ 6,580 | 现货 | ||
100 mg | ¥ 8,960 | 现货 | ||
500 mg | ¥ 17,900 | 现货 |
产品描述 | CCR2 antagonist 5 (JNJ-41443532) is a selective and orally active hCCR2 inhibitor with good binding affinity (IC50=37 nM) and potent functional antagonism (chemotaxis IC50=30 nM).JNJ-41443532 binds mCCR2 with a Ki of 9.6 µM, which can be used to study inflammatory diseases and diabetes. diseases and diabetes. |
靶点活性 | CCR2 (mouse):9.6 μM (Ki), CCR2 (human):37 nM (IC50) |
体内活性 |
CCR2 antagonist 5 (compound 8d) has good CV safety profile. It does not induce dose-dependent or notable effects on most cardiohemodynamic, functional respiratory, and electrophysiological parameters up to 10 mg/kg (i.v.) with plasma level at 70 µM in an anesthetized dog.[1] CCR2 antagonist 5 dose-dependently inhibits the influx of leukocytes, monocytes/macrophages, and T-lymphocytes into the peritoneal cavity with an ED50 of 3 mg/kg p.o. bid in a thioglycollate-induced peritonitis (TG) model.[1] CCR2 antagonist 5 has amendable oral bioavailability in dogs and primates.[1] |
别名 | JNJ-41443532, JNJ-41443532 Free Base, JNJ 41443532, JNJ41443532 |
分子量 | 482.52 |
分子式 | C22H25F3N4O3S |
CAS No. | 1228650-83-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (103.62 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0725 mL | 10.3623 mL | 20.7245 mL | 51.8113 mL |
5 mM | 0.4145 mL | 2.0725 mL | 4.1449 mL | 10.3623 mL | |
10 mM | 0.2072 mL | 1.0362 mL | 2.0725 mL | 5.1811 mL | |
20 mM | 0.1036 mL | 0.5181 mL | 1.0362 mL | 2.5906 mL | |
50 mM | 0.0414 mL | 0.2072 mL | 0.4145 mL | 1.0362 mL | |
100 mM | 0.0207 mL | 0.1036 mL | 0.2072 mL | 0.5181 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CCR2 antagonist 5 1228650-83-6 Immunology/Inflammation Microbiology/Virology CCR JNJ-41443532 JNJ-41443532 Free Base JNJ 41443532 JNJ41443532 Inhibitor inhibitor inhibit